Login to Your Account

U.S. Patent Disclosures

Thursday, July 14, 2011
Biomoda Inc., of Albuquerque, N.M., received a notice of allowance for a patent expanding the use of the CyPath assay to include patient response to cancer therapy during the treatment phase of the disease.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription